Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts
- 1 November 2021
- journal article
- review article
- Published by Springer Nature in Current Diabetes Reports
- Vol. 21 (11) , 1-16
Abstract
Purpose of Review This article reviews recent clinical efficacy research and economic analysis of the use of personal continuous glucose monitoring (CGM) in type 2 diabetes (T2D). Recent Findings Studies from the past 5 years include a variety of randomized controlled trials, meta-analyses, and other studies which generally favor CGM over self-monitoring of blood glucose (SMBG) in T2D, especially among people with T2D treated with insulin. Concurrently, some studies show no significant difference, but there is no evidence of worse outcomes with CGM. CGM is frequently associated with greater reduction in HbA1c than is SMBG. HbA1c reductions tend to be greater when baseline HbA1c is higher. Reductions in hypoglycemia and hyperglycemia have also been demonstrated with CGM in people with T2D, as have comfort with, preference for, and psychosocial benefits of CGM compared to SMBG. There is a small but growing evidence base on the economics and cost-effectiveness of CGM in T2D. Summary CGM has been clearly demonstrated to have clinical benefits in people with T2D, especially among those treated with insulin. Economic and cost-effectiveness data are more scant but are generally favorable. CGM should be an important consideration in the management of T2D, and its use is likely to increase as efficacy data accumulate further and as costs associated with CGM gradually decrease.Keywords
This publication has 35 references indexed in Scilit:
- Economic Costs of Diabetes in the U.S. in 2017Diabetes Care, 2018
- International Consensus on Use of Continuous Glucose MonitoringDiabetes Care, 2017
- Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab dataJournal of Medical Economics, 2017
- Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin InjectionsAnnals of Internal Medicine, 2017
- Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND TrialJournal of Diabetes Science and Technology, 2017
- Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled TrialDiabetes Therapy, 2016
- Improvement in Glucose Control in Difficult-to-Control Patients With Diabetes Using a Novel Flash Glucose Monitoring DeviceJournal of Diabetes Science and Technology, 2016
- Continuous Glucose Monitoring in the Self-management of Type 2 Diabetes: A Paradigm ShiftDiabetes Care, 2016
- The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 DiabetesJournal of Diabetes Science and Technology, 2016
- Hypoglycemia in Type 2 Diabetes - More Common Than You ThinkJournal of Diabetes Science and Technology, 2015